OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
PHBI
Pharmagreen Biotech Inc.
Common Stock
0.00092
-0.00008
-8.00%
0.0008 / 0.001 (1 x 1)
Real-Time Best Bid & Ask: 06:00am 07/11/2025
Delayed (15 Min) Trade Data: 12:00am 07/10/2025
0.00092
0.00092 - 0.00092
25,000
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
ETRF | 24.90 | >year | |
CDEL | 21.92 | 03/16 | |
MACM | 18.95 | >year | |
NITE | 18.95 | >year | |
CSTI | 18.55 | >year |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
INTL | 19.40 | >year | |
NITE | 19.40 | >year | |
MACM | 19.43 | >year | |
MAXM | 20.11 | >year | |
CANT | 22.05 | >year |
Unlock Real-Time quotes For PHBIFind Out More
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 07/10/2025 | 15:55:32 | 0.00092 | -0.00 | 25,000 |
| 07/09/2025 | 14:05:21 | 0.001 | 0.00 | 1,004 |
| 07/09/2025 | 13:36:44 | 0.0009 | -0.00 | 25,279 |
| 07/09/2025 | 11:52:57 | 0.001 | 0.00 | 78,000 |
| 07/09/2025 | 10:58:03 | 0.001 | 0.00 | 1,111 |
News
Pharmagreen Biotech Inc. (PHBI) Announces Exciting Revenue Potential for Its ProjectGlobeNewswire | 10/10/2024
Filings and Disclosure
Company Description
Pharmagreen Biotech Inc. (OTC Markets: PHBI) is developing its line of nutraceutical products, a proprietary blend of therapeutic plants and mushrooms. Pharmagreen's first new product, MaxGenomic(TM) Supplement, is a proprietary blend, formulated in the U. S. A., of nine medicinal mushrooms and six medicinal plants to help support the human mind and body. This supplement is produced in a U.S.A cGMP facility, in enteric capsules to enhance the bioavailability of the MaxGenomic(TM) supplement. Pharmagreen is also completing its research for its elixir, sublingual version, to provide immediate help and support to those who push their mental and physical capacity to their limits. Utilizing the Company's expertise in plant genetics, tissue culture, Pharmagreen's transgenic program uses the current technologies to research and create nutraceutical formulations as daily supplements, with the potential to improve lives and address a wide variety of aliments.
Videos
This company has not added any videos
OTCID
The Company Profile data was verified by the issuer within the previous 6 months.
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
The Shell Risk designation indicates that a company displays characteristics common to Shell Companies.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
57.00
Change
-2.25 (-3.80%)
Bid
57.40
Ask
58.70
Volume
2963
Time
00:00
